Trial · NCT03204786
Registered outcomes48
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 48
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | baseline, 4-week, 8-week | Social Responsiveness Scale, 2nd Edition (SRS) scores measure social abilities with lower scores meaning better social abilities. The SRS-2 is reported as a total score (T-Score Range: 37 to above 90), and the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5-compatible Social Communication and Interaction (SCI) score (T-Score Range: 36 to above 90) and Restricted Interests and Repetitive Behavior (RRB) score (T-Score range: 41 to above 90). A T-score of 50 indicates the population mean with a standard deviation of 10. Higher scores correspond to greater symptom levels (≤ 59: within normal limits; 60-65: mild range; 66-75: moderate range; ≥ 76: severe range). Change is reported as 4-week minus the baseline score, and 8-week minus the 4-week score. For this outcome, the baseline score is the average of the screening visit and baseline visit (average approximately 2 to 3 weeks after the screening visit). |
| Secondary | Change From Baseline in Clinical Global Impression (CGI) Scores During Treatment. | baseline; 4-week; 8-week | Clinician assessment of CGI severity (CGI-S) and CGI improvement (CGI-I) scores. * Higher scores on the CGI-S mean greater social and communication deficits (range: 1 to 7). * Lower scores on the CGI-I correspond to greater improvement in the areas assessed in the CGI-S, and higher scores correspond to worsening (range: 1 to 7). There is no baseline score for the CGI-I, it represents the clinician's subjective assessment of change. |
| Secondary | Change From Baseline on Reading the Mind in the Eyes Test (RMET) During Treatment. | baseline; 4-week; 8-week | Score range: 0 to 28; higher scores mean better ability to read emotions and lower scores mean worse ability to read emotions. |
| Secondary | Change From Baseline on the Facial Emotion Recognition Test During Treatment. | baseline; 4-week; 8-week | Score range: 0 to 42; higher scores mean better facial emotion recognition abilities. Lower scores mean worse facial emotion recognition abilities. |
| Secondary | Change From Baseline in Parent Rated Repetitive Behavior Scale Revised (RBS-R) Scores During Treatment. | baseline; 4-week; 8-week | Score range: 0 to 129; higher scores on the RBS-R mean higher levels of repetitive and restricted behaviors. |
| Secondary | Change From Baseline in Parent Rated Spence Children's Anxiety Scale (SCAS) During Treatment. | baseline; 4-week; 8-week | Scale measuring severity of anxiety symptoms. Score range: 0 to 114; higher scores mean higher levels of anxiety, lower scores mean lower levels of anxiety. |
| Secondary | Change From Baseline on Electrocardiogram (EKG) P Duration During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Electrocardiogram (EKG) PR Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Electrocardiogram (EKG) QRS Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Electrocardiogram (EKG) QT Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Sodium) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Potassium) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Chloride) During Treatment. | baseline to 4-week, 8-week, and 12-week | Change from baseline on blood clinical labs (Chloride) during treatment. |
| Secondary | Change From Baseline on Blood Clinical Labs (CO2) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Anion Gap) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Glucose) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Creatinine) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Urea Nitrogen) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Calcium) During Treatment. | baseline to 4-week, 8-week, and 12-week | |
| Secondary | Change From Baseline on Blood Clinical Labs (Osmolality) During Treatment. | baseline to 4-week, 8-week, and 12-week |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/registered